Position in AMGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,239,178
+$809,055 QoQ
Shares Held
29,101
+1.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. AMGN ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
This page
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
|
38,689 | $5,909,741 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,239,178 | 29,101 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,430,123 | 28,811 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,468,088 | 33,551 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $8,836,433 | 31,648 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $8,460,757 | 27,157 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,485,501 | 24,883 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,744,958 | 24,037 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,510,356 | 24,037 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,787,522 | 27,390 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $5,891,446 | 20,455 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,267,479 | 23,320 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,553,828 | 25,015 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $6,201,127 | 25,651 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $7,501,783 | 28,563 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,406,992 | 28,425 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,751,814 | 27,751 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $7,123,772 | 29,459 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $6,129,755 | 27,247 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,000,104 | 37,621 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,996,704 | 32,807 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,418,268 | 29,815 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $5,693,967 | 24,765 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $5,727,747 | 22,536 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,241,986 | 22,225 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $4,052,368 | 19,989 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||